These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 645)

  • 21. Regulation of B cell responses to the variant surface glycoprotein (VSG) molecule in trypanosomiasis. I. Epitope specificity and idiotypic profile of monoclonal antibodies to the VSG of Trypanosoma brucei rhodesiense.
    Theodos CM; Reinitz DM; Mansfield JM
    J Immunol; 1990 May; 144(10):4011-21. PubMed ID: 1692071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid method purifies a glycoprotein of Mr 145,000 as the LDL receptor of Trypanosoma brucei brucei.
    Coppens I; Bastin P; Courtoy PJ; Baudhuin P; Opperdoes FR
    Biochem Biophys Res Commun; 1991 Jul; 178(1):185-91. PubMed ID: 2069558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservation of structure detected in two trypanosome surface glycoproteins by amino acid sequence alignment.
    Barbet AF
    Mol Biochem Parasitol; 1985 Feb; 14(2):175-85. PubMed ID: 3838798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma brucei brucei: inhibition of glycosylation of the major variable surface coat glycoprotein by tunicamycin.
    Strickler JE; Patton CL
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1529-33. PubMed ID: 6929505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of antigenic determinants within peptides of a variant surface glycoprotein of Trypanosoma brucei.
    Miller EN; Allan LM; Turner MJ
    Mol Biochem Parasitol; 1984 Nov; 13(3):309-22. PubMed ID: 6084814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and quantification of variant specific antigen in the plasma of rats and mice infected with Trypanosoma brucei brucei.
    Diffley P; Strickler JE; Patton CL; Waksman BH
    J Parasitol; 1980 Apr; 66(2):185-91. PubMed ID: 6104691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosome sociology and antigenic variation.
    Vickerman K
    Parasitology; 1989; 99 Suppl():S37-47. PubMed ID: 2682484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MS and NMR analysis of the cross-reacting determinant glycan from Trypanosoma brucei brucei MITat 1.6 variant specific glycoprotein.
    Schmitz B; Klein RA; Duncan IA; Egge H; Gunawan J; Peter-Katalinic J; Dabrowski U; Dabrowski J
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1055-63. PubMed ID: 2441699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Instability of the Trypanosoma brucei rhodesiense metacyclic variable antigen repertoire.
    Barry JD; Crowe JS; Vickerman K
    Nature; 1983 Dec 15-21; 306(5944):699-701. PubMed ID: 6656871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversed phase HPLC of different membrane-bound variant surface glycoprotein preparations from Trypanosoma brucei brucei.
    Tetaert D; Hublart M; Gomès V; Boersma A; Degand P
    Biomed Chromatogr; 1989 Mar; 3(2):53-7. PubMed ID: 2736318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new method for the rapid purification of both the membrane-bound and released forms of the variant surface glycoprotein from Trypanosoma brucei.
    Jackson DG; Owen MJ; Voorheis HP
    Biochem J; 1985 Aug; 230(1):195-202. PubMed ID: 4052037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synthesis of a variant-specific antigen by Trypanosoma brucei in vitro.
    Taylor DW; Cross GA
    Parasitology; 1977 Feb; 74(1):47-60. PubMed ID: 65762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification of the 4S antigens of brucei subgroup trypanosomes.
    Njogu AR
    Trans R Soc Trop Med Hyg; 1972; 66(2):347-8. PubMed ID: 5065571
    [No Abstract]   [Full Text] [Related]  

  • 34. A characterization of mRNA activites and their sequence complexities in Trypanosoma brucei: partial purification and properties of the VSSA mRNA.
    Williams RO; Marcu KB; Young JR; Rovis L; Williams SC
    Nucleic Acids Res; 1978 Sep; 5(9):3171-82. PubMed ID: 704349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and isolation of a variant surface glycoprotein from Trypanosoma vivax.
    Gardiner PR; Pearson TW; Clarke MW; Mutharia LM
    Science; 1987 Feb; 235(4790):774-7. PubMed ID: 3810164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topologic mapping of protective and nonprotective epitopes on the variant surface glycoprotein of the WRATat 1 clone of Trypanosoma brucei rhodesiense.
    Hall T; Esser K
    J Immunol; 1984 Apr; 132(4):2059-63. PubMed ID: 6199421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Trypanosoma brucei activity in Cape buffalo serum during the cryptic phase of parasitemia is mediated by antibodies.
    Guirnalda P; Murphy NB; Nolan D; Black SJ
    Int J Parasitol; 2007 Oct; 37(12):1391-9. PubMed ID: 17583714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crossreacting determinants in the C-terminal region of trypanosome variant surface antigens.
    Cross GA
    Nature; 1979 Jan; 277(5694):310-2. PubMed ID: 84339
    [No Abstract]   [Full Text] [Related]  

  • 39. Release and purification of Trypanosoma brucei variant surface glycoprotein.
    Cross GA
    J Cell Biochem; 1984; 24(1):79-90. PubMed ID: 6725422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system.
    Dubois ME; Demick KP; Mansfield JM
    Infect Immun; 2005 May; 73(5):2690-7. PubMed ID: 15845470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.